Activating Compound | Comment | Organism | Structure |
---|---|---|---|
high molecular weight urokinase-type plasminogen activator | induces a significant increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes | Homo sapiens | |
low molecular weight urokinase-type plasminogen activator | induces a significant increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes | Homo sapiens | |
additional information | ATF-urokinase-type plasminogen activator causes little, if any, increase in plasmin activity in unstimulated or lipopolysaccharide-stimulated monocytes | Homo sapiens |
Application | Comment | Organism |
---|---|---|
medicine | binding of inactive plasmin to annexin A2 inhibits plasmin induction of matrix metalloproteinase-1. Inactive plasmin may be useful in suppressing inflammatory diseases that involve a series of proteases (e.g., matrix metalloproteinases) | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | inactive plasmin, in which the catalytic site has been irreversibly blocked with a peptide inhibitor | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
monocyte | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
annexin A2 + H2O | interaction of plasmin with annexin A2 results in the stimulation of ERK1/2 and p38 MAPK, cyclooxygenase-2, and PGE(2), leading to increased matrix metalloproteinase-1 production | Homo sapiens | ? | - |
? | |
H-D-norleucyl-hexahydrotyrosol-lysine-para nitroanilide diacetate + H2O | - |
Homo sapiens | ? | - |
? |